The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, China.
Br J Ophthalmol. 2021 Jan;105(1):27-31. doi: 10.1136/bjophthalmol-2019-315619. Epub 2020 Mar 22.
To evaluate the long-term outcomes of small incision lenticule extraction (SMILE) in subjects with myopic astigmatism of ≥2.00 dioptres (D).
Patients who underwent SMILE 4 years prior with astigmatism ≥2.00 D and ≤1.00 D were assigned to the high astigmatic group (HA group) or the low astigmatic group (LA group), respectively. The visual and refractive results as well as corneal wavefront aberrations were measured.
The preoperative cylinder was -2.47±0.54 D in 43 eyes in the HA group and -0.55±0.28 D in 31 eyes in the LA group. At 4 years, the residual cylinder was -0.31±0.29 D in the HA group and -0.20±0.28 D in the LA group (p=0.088). An uncorrected distance visual acuity of 20/20 was achieved in 88.4% of eyes in the HA group and 93.5% of eyes in the LA group. The efficacy index was 0.99±0.14 and 1.10±0.21 (p=0.025), and the safety index was 1.11±0.20 and 1.22±0.21 in the HA and LA groups, respectively (p=0.012). Eighty-six per cent and 90.3% of eyes were within ±0.50 D of the attempted cylindrical correction in the HA and LA groups, respectively. Vector analysis showed that the magnitude of error was -0.14±0.28 D and -0.05±0.16 D (p=0.085), the angle of error was -0.13±4.48 degrees and -2.57±29.42 degrees (p=0.592), the correction index was 0.94±0.13 and 0.94±0.35 (p=0.959), the index of success was 0.15±0.14 and 0.46±0.62 (p=0.517), and the flattening index was 0.93±0.13 and 0.71±0.59 (p=0.450) in the HA and LA groups, respectively.
This study demonstrates that SMILE is effective and safe for correcting high astigmatism. Vector analysis shows a tendency for the undercorrection of astigmatism in subjects with high astigmatism.
评估小切口微透镜提取术(SMILE)治疗近视散光≥2.00 屈光度(D)患者的长期疗效。
将 4 年前接受 SMILE 治疗且散光≥2.00 D 且≤1.00 D 的患者分别分配至高度散光组(HA 组)或低度散光组(LA 组)。测量视力和屈光结果以及角膜波前像差。
HA 组 43 只眼中术前柱镜度为-2.47±0.54 D,LA 组 31 只眼中为-0.55±0.28 D。4 年后,HA 组残余柱镜度为-0.31±0.29 D,LA 组为-0.20±0.28 D(p=0.088)。HA 组 88.4%的眼和 LA 组 93.5%的眼获得 20/20 未矫正远视力。功效指数分别为 0.99±0.14 和 1.10±0.21(p=0.025),安全性指数分别为 1.11±0.20 和 1.22±0.21,HA 和 LA 组分别为 1.11±0.20 和 1.22±0.21(p=0.012)。HA 和 LA 组分别有 86%和 90.3%的眼在尝试的圆柱镜矫正范围内±0.50 D。向量分析显示,误差幅度分别为-0.14±0.28 D 和-0.05±0.16 D(p=0.085),误差角分别为-0.13±4.48 度和-2.57±29.42 度(p=0.592),矫正指数分别为 0.94±0.13 和 0.94±0.35(p=0.959),成功率指数分别为 0.15±0.14 和 0.46±0.62(p=0.517),HA 和 LA 组的扁平度指数分别为 0.93±0.13 和 0.71±0.59(p=0.450)。
本研究表明 SMILE 治疗高度散光有效且安全。向量分析显示,高度散光患者存在散光欠矫的趋势。